Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nexvet Biopharma Plc (NVET) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nexvet Biopharma Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1618561.
Total stock buying since 2015: $1,335,036.
Total stock sales since 2015: $431.
Total stock option exercises since 2015: $45,544.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2017 | 0 | $0 | 0 | $0 | 168,072 | $21,003 |
| 2016 | 48,739 | $161,138 | 132 | $431 | 97,223 | $12,161 |
| 2015 | 131,100 | $1,173,898 | 0 | $0 | 99,115 | $12,380 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2017-07 | 0 | $0 | 0 | $0 | 164,072 | $20,507 |
| 2017-06 | 0 | $0 | 0 | $0 | 2,000 | $248 |
| 2017-03 | 0 | $0 | 0 | $0 | 2,000 | $248 |
| 2016-12 | 0 | $0 | 0 | $0 | 2,000 | $248 |
| 2016-09 | 0 | $0 | 0 | $0 | 2,000 | $248 |
| 2016-07 | 0 | $0 | 0 | $0 | 89,223 | $11,169 |
| 2016-06 | 0 | $0 | 0 | $0 | 2,000 | $248 |
| 2016-03 | 12,613 | $41,838 | 132 | $431 | 2,000 | $248 |
| 2016-02 | 36,126 | $119,300 | 0 | $0 | 0 | $0 |
| 2015-12 | 0 | $0 | 0 | $0 | 2,000 | $248 |
| 2015-11 | 0 | $0 | 0 | $0 | 64,036 | $8,002 |
| 2015-09 | 31,100 | $173,898 | 0 | $0 | 2,000 | $248 |
| 2015-07 | 0 | $0 | 0 | $0 | 17,699 | $2,211 |
| 2015-06 | 0 | $0 | 0 | $0 | 9,680 | $1,209 |
| 2015-05 | 0 | $0 | 0 | $0 | 3,700 | $462 |
| 2015-02 | 100,000 | $1,000,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-07-01 | Horn Jurgen (Chief Product Development Ofcr) | Option Ex | 15,750 | .12 | 1,968 |
| 2017-07-01 | Gunn George W (Director) | Option Ex | 3,600 | .12 | 450 |
| 2017-07-01 | Mccracken Joseph S (Director) | Option Ex | 3,600 | .12 | 450 |
| 2017-07-01 | Kilty Cormac G (Director) | Option Ex | 3,600 | .12 | 450 |
| 2017-07-01 | Heffernan Mark (Chief Executive Officer) | Option Ex | 60,643 | .12 | 7,580 |
| 2017-07-01 | Hanna Ashraf (Director) | Option Ex | 3,600 | .12 | 450 |
| 2017-07-01 | Brown Christopher Nigel (Director) | Option Ex | 3,600 | .12 | 450 |
| 2017-07-01 | Farrell Geraldine T (VP Operations, General Counsel) | Option Ex | 21,400 | .12 | 2,675 |
| 2017-07-01 | Payne John Bernard (Director) | Option Ex | 3,600 | .12 | 450 |
| 2017-07-01 | Lismore Damian T. (Chief Financial Officer) | Option Ex | 41,079 | .12 | 5,134 |
| 2017-07-01 | Patel Rajiv A | Option Ex | 3,600 | .12 | 450 |
| 2017-06-30 | Gunn George W (Director) | Option Ex | 500 | .12 | 62 |
| 2017-06-30 | Mccracken Joseph S (Director) | Option Ex | 500 | .12 | 62 |
| 2017-06-30 | Hanna Ashraf (Director) | Option Ex | 500 | .12 | 62 |
| 2017-06-30 | Patel Rajiv A | Option Ex | 500 | .12 | 62 |
| 2017-03-31 | Gunn George W (Director) | Option Ex | 500 | .12 | 62 |
| 2017-03-31 | Mccracken Joseph S (Director) | Option Ex | 500 | .12 | 62 |
| 2017-03-31 | Hanna Ashraf (Director) | Option Ex | 500 | .12 | 62 |
| 2017-03-31 | Patel Rajiv A | Option Ex | 500 | .12 | 62 |
| 2016-12-31 | Gunn George W (Director) | Option Ex | 500 | .12 | 62 |
| 2016-12-31 | Mccracken Joseph S (Director) | Option Ex | 500 | .12 | 62 |
| 2016-12-31 | Hanna Ashraf (Director) | Option Ex | 500 | .12 | 62 |
| 2016-12-31 | Patel Rajiv A | Option Ex | 500 | .12 | 62 |
| 2016-09-30 | Gunn George W (Director) | Option Ex | 500 | .12 | 62 |
| 2016-09-30 | Mccracken Joseph S (Director) | Option Ex | 500 | .12 | 62 |
| 2016-09-30 | Hanna Ashraf (Director) | Option Ex | 500 | .12 | 62 |
| 2016-09-30 | Patel Rajiv A | Option Ex | 500 | .12 | 62 |
| 2016-07-01 | Gunn George W (Director) | Option Ex | 3,600 | .12 | 450 |
| 2016-07-01 | Gearing David (Chief Scientific Officer) | Option Ex | 11,233 | .12 | 1,404 |
| 2016-07-01 | Mccracken Joseph S (Director) | Option Ex | 3,600 | .12 | 450 |
| 2016-07-01 | Kilty Cormac G (Director) | Option Ex | 3,600 | .12 | 450 |
| 2016-07-01 | Heffernan Mark (Chief Executive Officer) | Option Ex | 29,833 | .12 | 3,729 |
| 2016-07-01 | Hanna Ashraf (Director) | Option Ex | 3,600 | .12 | 450 |
| 2016-07-01 | Brown Christopher Nigel (Director) | Option Ex | 3,600 | .13 | 468 |
| 2016-07-01 | Farrell Geraldine T (VP Operations, General Counsel) | Option Ex | 5,207 | .12 | 650 |
| 2016-07-01 | Payne John Bernard (Director) | Option Ex | 3,600 | .12 | 450 |
| 2016-07-01 | Lismore Damian T. (Chief Financial Officer) | Option Ex | 17,750 | .12 | 2,218 |
| 2016-07-01 | Patel Rajiv A | Option Ex | 3,600 | .12 | 450 |
| 2016-06-30 | Gunn George W (Director) | Option Ex | 500 | .12 | 62 |
| 2016-06-30 | Mccracken Joseph S (Director) | Option Ex | 500 | .12 | 62 |
| 2016-06-30 | Hanna Ashraf (Director) | Option Ex | 500 | .12 | 62 |
| 2016-06-30 | Patel Rajiv A | Option Ex | 500 | .12 | 62 |
| 2016-03-31 | Gunn George W (Director) | Option Ex | 500 | .12 | 62 |
| 2016-03-31 | Mccracken Joseph S (Director) | Option Ex | 500 | .12 | 62 |
| 2016-03-31 | Hanna Ashraf (Director) | Option Ex | 500 | .12 | 62 |
| 2016-03-31 | Patel Rajiv A | Option Ex | 500 | .12 | 62 |
| 2016-03-04 | Gearing David (CHIEF SCIENTIFIC OFFICER) | Buy | 9,000 | 3.35 | 30,150 |
| 2016-03-03 | Gearing David (CHIEF SCIENTIFIC OFFICER) | Buy | 2,113 | 3.26 | 6,888 |
| 2016-03-03 | Farrell Geraldine T (VP Operations, General Counsel) | Sale | 132 | 3.27 | 431 |
| 2016-03-02 | Hanna Ashraf (Director) | Buy | 1,500 | 3.20 | 4,800 |
| 2016-02-26 | Gearing David (Chief Scientific Officer) | Buy | 12,126 | 3.34 | 40,500 |
| 2016-02-25 | Gearing David (Chief Scientific Officer) | Buy | 19,000 | 3.30 | 62,700 |
| 2016-02-18 | Lismore Damian T. (Chief Financial Officer) | Buy | 5,000 | 3.22 | 16,100 |
| 2015-12-31 | Gunn George W (Director) | Option Ex | 500 | .12 | 62 |
| 2015-12-31 | Mccracken Joseph S (Director) | Option Ex | 500 | .12 | 62 |
| 2015-12-31 | Hanna Ashraf (Director) | Option Ex | 500 | .12 | 62 |
| 2015-12-31 | Patel Rajiv A | Option Ex | 500 | .12 | 62 |
| 2015-11-23 | Gearing David (Chief Scientific Officer) | Option Ex | 5,600 | .12 | 700 |
| 2015-11-23 | Heffernan Mark (Chief Executive Officer) | Option Ex | 7,250 | .12 | 906 |
| 2015-11-23 | Farrell Geraldine T (VP Operations, General Counsel) | Option Ex | 4,300 | .12 | 537 |
| 2015-11-23 | Lismore Damian T. (CHIEF FINANCIAL OFFICER) | Option Ex | 6,000 | .12 | 750 |
| 2015-11-20 | Heffernan Mark (Chief Executive Officer) | Option Ex | 9,204 | .12 | 1,150 |
| 2015-11-17 | Lismore Damian T. (Chief Financial Officer) | Option Ex | 7,080 | .12 | 885 |
| 2015-11-07 | Gearing David (Chief Scientific Officer) | Option Ex | 9,203 | .12 | 1,150 |
| 2015-11-05 | Gearing David (Chief Scientific Officer) | Option Ex | 9,204 | .12 | 1,150 |
| 2015-11-05 | Farrell Geraldine T (VP Operations, General Counsel) | Option Ex | 6,195 | .12 | 774 |
| 2015-09-30 | Gunn George W (Director) | Option Ex | 500 | .12 | 62 |
| 2015-09-30 | Mccracken Joseph S (Director) | Option Ex | 500 | .12 | 62 |
| 2015-09-30 | Hanna Ashraf (Director) | Option Ex | 500 | .12 | 62 |
| 2015-09-30 | Patel Rajiv A | Option Ex | 500 | .12 | 62 |
| 2015-09-10 | Spokes Andrew J M | Buy | 10,800 | 6.48 | 69,984 |
| 2015-09-09 | Gunn George W (Director) | Buy | 10,000 | 5.43 | 54,330 |
| 2015-09-09 | Kilty Cormac G (Director) | Buy | 10,000 | 4.79 | 47,859 |
| 2015-09-09 | Spokes Andrew J M | Buy | 300 | 5.75 | 1,725 |
| 2015-07-15 | Wald Graeme (Director) | Option Ex | 3,600 | .12 | 450 |
| 2015-07-13 | Gunn George W (Director) | Option Ex | 1,400 | .12 | 175 |
| 2015-07-01 | Giles Colin (VP Clinical&Regulatory Affairs) | Option Ex | 2,098 | .12 | 262 |
| 2015-07-01 | Gearing David (CHIEF SCIENTIFIC OFFICER) | Option Ex | 3,734 | .12 | 466 |
| 2015-07-01 | Farrell Geraldine T (VP Operations, General Counsel) | Option Ex | 2,867 | .12 | 358 |
| 2015-07-01 | Lismore Damian T. (CHIEF FINANCIAL OFFICER) | Option Ex | 4,000 | .12 | 500 |
| 2015-06-30 | Mccracken Joseph S (Director) | Option Ex | 1,400 | .12 | 175 |
| 2015-06-30 | Kilty Cormac G (Director) | Option Ex | 3,600 | .12 | 450 |
| 2015-06-30 | Hanna Ashraf (Director) | Option Ex | 1,400 | .12 | 175 |
| 2015-06-30 | Payne John Bernard (Director) | Option Ex | 900 | .12 | 112 |
| 2015-06-30 | Patel Rajiv A | Option Ex | 1,400 | .12 | 175 |
| 2015-06-15 | Patel Rajiv A | Option Ex | 980 | .12 | 122 |
| 2015-05-18 | Mccracken Joseph S (Director) | Option Ex | 1,400 | .12 | 175 |
| 2015-05-18 | Hanna Ashraf (Director) | Option Ex | 1,400 | .12 | 175 |
| 2015-05-18 | Payne John Bernard (Director) | Option Ex | 900 | .12 | 112 |
| 2015-02-10 | One Funds Management Ltd Atf Asia Pacific Healthcare Fund Ii (10% Owner) | Buy | 100,000 | 10.00 | 1,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NVET listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nexvet Biopharma Plc (symbol NVET, CIK number 1618561) see the Securities and Exchange Commission (SEC) website.